###begin article-title 0
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 64 72 <span type="species:ncbi:9606">Patients</span>
Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant
###end article-title 0
###begin p 1
###xml 1170 1173 1170 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 1178 1181 1178 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 1048 1071 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 1769 1774 <span type="species:ncbi:9606">human</span>
Ribonuclease L (RNase L) is an important effector of the innate antiviral response. Mutations or variants that impair function of RNase L, particularly R462Q, have been proposed as susceptibility factors for prostate cancer. Given the role of this gene in viral defense, we sought to explore the possibility that a viral infection might contribute to prostate cancer in individuals harboring the R462Q variant. A viral detection DNA microarray composed of oligonucleotides corresponding to the most conserved sequences of all known viruses identified the presence of gammaretroviral sequences in cDNA samples from seven of 11 R462Q-homozygous (QQ) cases, and in one of eight heterozygous (RQ) and homozygous wild-type (RR) cases. An expanded survey of 86 tumors by specific RT-PCR detected the virus in eight of 20 QQ cases (40%), compared with only one sample (1.5%) among 66 RQ and RR cases. The full-length viral genome was cloned and sequenced independently from three positive QQ cases. The virus, named XMRV, is closely related to xenotropic murine leukemia viruses (MuLVs), but its sequence is clearly distinct from all known members of this group. Comparison of gag and pol sequences from different tumor isolates suggested infection with the same virus in all cases, yet sequence variation was consistent with the infections being independently acquired. Analysis of prostate tissues from XMRV-positive cases by in situ hybridization and immunohistochemistry showed that XMRV nucleic acid and protein can be detected in about 1% of stromal cells, predominantly fibroblasts and hematopoietic elements in regions adjacent to the carcinoma. These data provide to our knowledge the first demonstration that xenotropic MuLV-related viruses can produce an authentic human infection, and strongly implicate RNase L activity in the prevention or clearance of infection in vivo. These findings also raise questions about the possible relationship between exogenous infection and cancer development in genetically susceptible individuals.
###end p 1
###begin title 2
Synopsis
###end title 2
###begin p 3
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 412 419 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL,</italic>
###xml 1241 1247 1241 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 96 99 <span type="species:ncbi:9606">men</span>
###xml 980 1003 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 1056 1061 <span type="species:ncbi:9606">human</span>
###xml 1217 1225 <span type="species:ncbi:9606">patients</span>
Prostate cancer is the most frequent cancer and the second leading cause of cancer deaths in US men over the age of 50. Several genetic factors have been proposed as potential risk factors for the development of prostate cancer, including a viral defense gene called RNASEL. A common genetic variant in this gene, R462Q, was recently implicated in up to 13% of prostate cancer cases. Given the antiviral role of RNASEL, the authors sought to examine if a virus might be present in prostate cancers associated with the R462Q variant. Using a DNA microarray designed to detect all known viral families, the authors identified a novel virus, named XMRV, in a subset of prostate tumor samples. Polymerase chain reaction testing of 86 prostate tumors for the presence of XMRV revealed a strong association between the presence of the virus and being homozygous for the R462Q variant. Cloning and sequencing of the virus showed that XMRV is a close relative of several known xenotropic murine leukemia viruses. This report presents the first documented cases of human infection with a xenotropic retrovirus. Future work will address the potential connection between XMRV infection and the increased prostate cancer risk in patients with the R462Q RNASEL variant.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b001">1</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b002">2</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b003">3</xref>
###xml 568 571 568 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b004">4</xref>
###xml 703 704 703 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b005">5</xref>
###xml 835 836 835 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b004">4</xref>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b006">6</xref>
###xml 839 840 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b008">8</xref>
###xml 1004 1005 1004 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b009">9</xref>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 650 676 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
###xml 682 699 <span type="species:ncbi:12073">Coxsackievirus B4</span>
Type I interferons (IFNs) are rapidly mobilized in response to viral infection and trigger potent antiviral responses. One such response is the induction by IFN of a family of 2'5' oligoadenylate synthetases (OAS); upon activation by virally encoded dsRNA, these enzymes produce 5'-phosphorylated 2'-5' linked oligoadenylates (2-5A) from ATP [1]. 2-5A, in turn, is an activator of ribonuclease L (RNase L) [2], which degrades viral (and cellular) single stranded RNAs [3]. In vivo evidence for the antiviral role of the 2-5A system was provided by studies with RNase L-/- mice, which have enhanced susceptibility to infections by the picornaviruses, encephalomyocarditis virus, and Coxsackievirus B4 [4,5]. Ultimately, sustained activation of RNase L triggers a mitochondrial pathway of apoptosis that eliminates virus-infected cells [4,6-8]. Genetic lesions in RNase L impair this apoptotic response, which has raised interest in the possibility that such mutations might also contribute to malignancy [9].
###end p 5
###begin p 6
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b010">10</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b013">13</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b014">14</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b015">15</xref>
###xml 721 726 721 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPC1,</italic>
###xml 740 746 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b010">10</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b011">11</xref>
###xml 798 809 798 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPC1/RNASEL</italic>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b010">10</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b013">13</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b016">16</xref>
###xml 1220 1222 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b011">11</xref>
###xml 1518 1519 1518 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b009">9</xref>
###xml 1520 1522 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b011">11</xref>
###xml 1625 1631 1625 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 1693 1695 1693 1695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b010">10</xref>
###xml 1696 1698 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b013">13</xref>
###xml 1716 1718 1716 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b017">17</xref>
###xml 1719 1721 1719 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b019">19</xref>
###xml 1822 1828 1822 1828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
In this context, several recent studies have linked germline mutations in RNase L to prostate cancer susceptibility [10-13]. Prostate cancer has a complex etiology influenced by androgens, diet, and other environmental and genetic factors [14]. While sporadic prostate cancer displays an age-related increase in prevalence, familial prostate cancer kindreds often display early-onset disease. Such kindreds, defined by having more than three affected members per family, account for 43% of early onset cases (<55 years old) and 9% of all cases [15]. The genetics of hereditary prostate cancer (HPC) is complex, and several genes have been proposed as susceptibility factors in this syndrome. Interestingly, one of these, HPC1, is linked to RNASEL [10,11]. Several germline mutations or variants in HPC1/RNASEL have been observed in HPC [10-13] (reviewed in [16]), including a common (35% allelic frequency) missense variant of RNase L, in which a G to A transition at nucleotide (nt) position 1385 (G1385A) results in a glutamine instead of arginine at amino acid position 462 (R462Q). Remarkably, a large, controlled sib-pair study implicated the R462Q RNase L variant in up to 13% of unselected prostate cancer cases [11]. One copy of the mutated gene increased the risk of prostate cancer by about 50%, whereas individuals that were homozygous for the mutation had a 2-fold increased risk of prostate cancer. The R462Q RNase L variant had a 3-fold decrease in catalytic activity compared with the wild-type enzyme [9,11]. However, while several case-controlled genetic and epidemiologic studies support the involvement of RNASEL (and notably the R462Q variant) in prostate cancer etiology [10-13], others do not [17-19], suggesting that either population differences or environmental factors may modulate the impact of RNASEL on prostatic carcinogenesis.
###end p 6
###begin p 7
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b020">20</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b021">21</xref>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 803 826 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 1208 1214 <span type="species:ncbi:9606">humans</span>
While the antiapoptotic phenotype of RNase L deficiency has dominated previous discussions of its possible linkage to cancer, RNase L is also a key effector of the antiviral action of interferons. This led us to consider the possibility that the putative linkage of RNase L alterations to HPC might reflect enhanced susceptibility to a viral agent. To test this hypothesis, we have examined RNA derived from wild-type and RNase L variant (R462Q) prostate tumors for evidence of viral sequences, by hybridization to a DNA microarray composed of the most conserved sequences of all known human, animal, plant, and bacterial viruses [20,21]. Here we report that 40% (eight of 20) of all tumors homozygous for the R462Q allele harbored the genome of a distinct gammaretrovirus closely related to xenotropic murine leukemia viruses (MuLVs). In contrast, retroviral sequences were present in <2% of tumors bearing at least one copy of the wild-type allele (one of 66). In addition, virus-harboring cells were detected within infected prostatic tumor tissues by fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). These findings represent the first detection of xenotropic MuLV-like agents in humans, and reveal a strong association between infection with the virus and defects in RNase L activity. The relation of retroviral infection to prostate cancer will require further study, but a cofactor role is not excluded.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
Detection of XMRV by Microarray-Based Screening
###end title 9
###begin p 10
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b020">20</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b021">21</xref>
To search for potential viruses in prostate cancer tumors, we employed a DNA microarray-based strategy designed to screen for viruses from all known viral families [20,21]. Total or polyadenylated RNA extracted from tumor tissue was first amplified and fluorescently labeled in a sequence-nonspecific fashion. The amplified and labeled fragments, which contained host as well as potential viral sequences, were then hybridized to a DNA microarray (Virochip, University of California San Francisco, San Francisco, United States) bearing the most conserved sequences of ~950 fully sequenced NCBI reference viral genomes (~11,000 70-mer oligonucleotides).
###end p 10
###begin p 11
###xml 93 101 93 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g001">Figure 1</xref>
###xml 242 248 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 457 465 457 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g001">Figure 1</xref>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b022">22</xref>
###xml 753 761 753 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st001">Table S1</xref>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
The Virochip was used to screen RNA samples isolated from prostate tumors of 19 individuals (Figure 1). A positive hybridization signal suggestive of a gammaretrovirus was detected in seven of 11 tumors from patients homozygous for the R462Q RNASEL variant (QQ). In contrast, no virus was detected in three tumors from RQ heterozygotes, and only one of five tumors from RR individuals was positive. Clustering of the microarray oligonucleotide intensities (Figure 1) revealed a similar hybridization pattern in all positive cases. Furthermore, a computational analysis using E-Predict, a recently described algorithm for viral species identification [22], suggested that the same or similar mammalian gammaretrovirus was present in all positive tumors (Table S1). Thus, the Virochip detected the presence of a probable gammaretrovirus in half of the QQ tumor samples and in only one non-QQ sample.
###end p 11
###begin title 12
Characterization of XMRV Genome
###end title 12
###begin p 13
###xml 97 105 97 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">Figure 2</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b021">21</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b023">23</xref>
###xml 1218 1226 1218 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">Figure 2</xref>
###xml 1232 1240 1232 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st002">Table S2</xref>
###xml 1557 1565 1557 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">Figure 2</xref>
###xml 607 613 <span type="species:ncbi:10090">murine</span>
###xml 643 669 <span type="species:ncbi:11819">spleen focus-forming virus</span>
###xml 671 675 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 824 829 <span type="species:ncbi:10090">mouse</span>
To further characterize the virus, we recovered its entire genome from one of the tumors (VP35) (Figure 2). To obtain viral clones, we first employed a direct microarray recovery technique described previously [21]. Briefly, amplified nucleic acid from the tumor tissue, which hybridized to viral microarray oligonucleotides, was eluted from two specific spots. The eluted DNA was re-amplified, and plasmid libraries constructed from this material were screened by colony hybridization using the spots' oligonucleotides as probes. The array oligonucleotides used in this case derived from the LTR region of murine type C retrovirus (MTCR) and spleen focus-forming virus (SFFV) [23]. The largest recovered fragment was 415 nt in length, and had 96% nt identity to the LTR region of MTCR, a MuLV identified in the genome of a mouse myeloma cell line (T. Heinemeyer, unpublished data). These findings established that the virus in question was indeed a gammaretrovirus, and likely a relative of MuLVs. To clone and sequence the rest of the viral genome from sample VP35, we used tumor cDNA to PCR-amplify overlapping segments using primers derived from MTCR; gaps were closed using primers from earlier recovered clones (Figure 2B and Table S2). Using a similar strategy, we have also determined the full sequence of the virus from a second tumor, VP42. Finally, a complete viral genomic sequence from a third tumor case, VP62, was obtained by PCR amplification of two ~4 Kb-long overlapping fragments jointly spanning close to the entire length of the virus (Figure 2B). The three sequenced genomes share >98% nt identity overall and >99% amino acid (aa) identity for predicted open reading frames (ORFs), and thus represent the same virus.
###end p 13
###begin p 14
###xml 30 39 30 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">Figures 2</xref>
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg001">S1</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b024">24</xref>
###xml 392 404 392 404 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Mus musculus</named-content>
###xml 428 436 428 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">Figure 2</xref>
###xml 596 605 596 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g003">Figures 3</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg002">S2</xref>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 392 404 <span type="species:ncbi:10090">Mus musculus</span>
###xml 582 587 <span type="species:ncbi:10090">mouse</span>
###xml 781 810 <span type="species:ncbi:438045">Xenotropic MuLV-related virus</span>
###xml 812 816 <span type="species:ncbi:438045">XMRV</span>
The full genome of the virus (Figures 2 and S1) is 8,185 nt long and is distinct from all known isolates of MuLV. The genome is most similar to the genomes of exogenous MuLVs, DG-75 cloned from a human B-lymphoblastoid cell line [24], and MTCR, with which it shares 94% and 93% overall nt sequence identity, respectively. The genome also shares up to 95% nt identity with several full-length Mus musculus endogenous proviruses (Figure 2C). Phylogenetic trees constructed using available mammalian type C retroviral genomes and representative full-length proviral sequences from the mouse genome (Figures 3 and S2) showed that the newly identified virus is more similar to xenotropic and polytropic than to ecotropic genomes. Based on these findings we propose the provisional name Xenotropic MuLV-related virus (XMRV) for this agent.
###end p 14
###begin p 15
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b025">25</xref>
###xml 343 354 343 354 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. musculus</named-content>
###xml 407 416 407 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg002">Figure S2</xref>
###xml 538 549 538 549 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. musculus</named-content>
###xml 591 600 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg002">Figure S2</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b026">26</xref>
###xml 19 23 <span type="species:ncbi:438045">XMRV</span>
###xml 237 241 <span type="species:ncbi:438045">XMRV</span>
###xml 343 354 <span type="species:ncbi:10090">M. musculus</span>
###xml 538 549 <span type="species:ncbi:10090">M. musculus</span>
Translation of the XMRV genomic sequence using ORF Finder [25] identified two overlapping ORFs coding for the full-length Gag-Pro-Pol and Env polyproteins. No exogenous coding sequences, such as viral oncogenes, could be detected in the XMRV genome. The predicted Gag polyprotein is 536 aa long and is most similar to a xenotropic provirus on M. musculus Chromosome 9, with which it shares 97% aa identity (Figure S2A). The Pro-Pol polyprotein is 1,197 aa long and has the highest aa identity with MuLV DG-75 and a xenotropic provirus on M. musculus Chromosome 4, 97% and 96%, respectively (Figure S2B). An amber (UAG) stop codon separates the Gag and Pro-Pol coding sequences, analogous to other MuLVs in which a translational read-through is required to generate the full-length Gag-Pro-Pol polyprotein (reviewed in [26]).
###end p 15
###begin p 16
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b023">23</xref>
###xml 27 29 27 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b024">24</xref>
###xml 30 32 30 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b027">27</xref>
###xml 33 35 33 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b031">31</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b032">32</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b028">28</xref>
###xml 509 518 509 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg002">Figure S2</xref>
###xml 646 649 646 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b033">33</xref>
###xml 848 856 848 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g004">Figure 4</xref>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b034">34</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b036">36</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b037">37</xref>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b038">38</xref>
###xml 1357 1359 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b040">40</xref>
###xml 61 65 <span type="species:ncbi:438045">XMRV</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 413 417 <span type="species:ncbi:438045">XMRV</span>
###xml 479 485 <span type="species:ncbi:10090">murine</span>
###xml 772 776 <span type="species:ncbi:438045">XMRV</span>
###xml 984 988 <span type="species:ncbi:438045">XMRV</span>
###xml 1108 1112 <span type="species:ncbi:438045">XMRV</span>
###xml 1263 1267 <span type="species:ncbi:438045">XMRV</span>
Similar to other MuLVs [23,24,27-31], the Env polyprotein of XMRV is in a different reading frame compared with Gag-Pro-Pol. The Env protein sequence is 645 aa long, and has the highest amino acid identity with the Env protein of an infectious MuLV isolated from a human small cell lung cancer line NCI-417 [32] and MuLV New Zealand Black 9-1 xenotropic retrovirus (NZB-9-1) [28]), 95% and 94%, respectively. The XMRV Env protein also shares similarly high identity with several murine xenotropic proviruses (Figure S2C). Conserved splice donor (AGGTAAG, position 204) and acceptor (CACTTACAG, position 5,479) sites involved in the generation of env subgenomic RNAs [33] were found in the same relative locations as in other MuLV genomes. A multiple sequence alignment of XMRV Env and corresponding protein sequences of other representative MuLVs (Figure 4) showed that within three highly variable regions (VR), VRA, VRB, and VRC, known to be important for cellular tropism [34-36], XMRV has the highest aa identity with xenotropic envelopes from MuLVs NZB-9-1, NFS-Th-1 [37], and DG-75. Although unique-to-XMRV aa are present in each of the three VRs, based on the overall similarity to the known xenotropic envelopes, we predict that the cellular receptor for XMRV is XPR1 (SYG1), the recently identified receptor for xenotropic and polytropic MuLVs [38-40].
###end p 16
###begin p 17
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b033">33</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b041">41</xref>
###xml 388 397 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg003">Figure S3</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b042">42</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b045">45</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b046">46</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b047">47</xref>
###xml 1078 1087 1078 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg003">Figure S3</xref>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b048">48</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b049">49</xref>
###xml 1364 1373 1364 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg003">Figure S3</xref>
###xml 34 38 <span type="species:ncbi:438045">XMRV</span>
###xml 160 164 <span type="species:ncbi:438045">XMRV</span>
###xml 898 902 <span type="species:ncbi:10090">mice</span>
###xml 974 978 <span type="species:ncbi:438045">XMRV</span>
###xml 1174 1178 <span type="species:ncbi:438045">XMRV</span>
###xml 1255 1259 <span type="species:ncbi:438045">XMRV</span>
The long terminal repeat (LTR) of XMRV is 535 nt long and has the highest nt identity with the LTRs from xenotropic MuLVs NFS-Th-1 (96%) and NZB-9-1 (94%). The XMRV LTRs contain known structural and regulatory elements typical of other MuLV LTRs [33,41]. In particular, the CCAAT box, TATAAAA box, and AATAAA polyadenylation signal sequences were found in U3 at their expected locations (Figure S3A). U3 also contains a glucocorticoid response element sequence AGA ACA GAT GGT CCT. Essentially identical sequences are present in genomes of other MuLVs. These elements have been shown to activate LTR-directed transcription and viral replication in vitro in response to various steroids including androgens [42-45]. In addition, presence of an intact glucocorticoid response element is thought to be the determinant of higher susceptibility to FIS-2 MuLV infection in male compared with female NMRI mice [46,47]. Despite these similarities, single nt substitutions unique to XMRV and an insertion of an AG dinucleotide immediately downstream from the TATA box are present in U3 (Figure S3A). Consistent with these findings, a phylogenetic analysis based on U3 sequences from XMRV and from representative xenotropic MuLV provirus groups [48,49] showed that XMRV U3 sequences formed a well-separated cluster most similar to the group containing NFS-Th-1 and NZB-9-1 (Figure S3B).
###end p 17
###begin p 18
###xml 7 10 7 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag,</italic>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b050">50</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b051">51</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b052">52</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b053">53</xref>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag.</italic>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g005">Figures 5</xref>
###xml 536 537 536 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">2</xref>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b054">54</xref>
###xml 848 851 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 1288 1296 1288 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g005">Figure 5</xref>
###xml 1387 1389 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b055">55</xref>
###xml 1390 1392 1390 1392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b056">56</xref>
###xml 1512 1514 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b057">57</xref>
###xml 1515 1517 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b061">61</xref>
###xml 1761 1763 1761 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b062">62</xref>
###xml 1986 1988 1986 1988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b058">58</xref>
###xml 21 25 <span type="species:ncbi:438045">XMRV</span>
###xml 732 736 <span type="species:ncbi:438045">XMRV</span>
###xml 1050 1054 <span type="species:ncbi:438045">XMRV</span>
###xml 1274 1279 <span type="species:ncbi:10090">mouse</span>
###xml 1954 1958 <span type="species:ncbi:10090">mice</span>
###xml 2064 2068 <span type="species:ncbi:438045">XMRV</span>
###xml 2261 2266 <span type="species:ncbi:9606">human</span>
The 5' gag leader of XMRV, defined as the sequence extending from the end of U5 to the ATG start codon of gag, consists of a conserved non-coding region of ~200 nt, containing a proline tRNA primer binding site as well as sequences required for viral packaging [50,51] and the initiation of translation [52,53]. The non-coding region is followed by a ~270-nt region extending from the conserved CTG alternative start codon of gag. This region represents the most divergent segment of the genome compared with other MuLVs (Figures 5 and 2C). Unlike ecotropic MuLVs, where translation from this codon adds an ~90 aa N-terminal leader peptide in frame with the rest of the Gag protein, thus generating a glycosylated form of Gag [54], XMRV has a stop codon 53 aa residues downstream from the alternative start. Interestingly, both MuLV DG-75 and MTCR gag leader sequences are also interrupted by stop codons, and therefore are not expected to produce full-length glyco-Gag. Furthermore, a characteristic 24-nt deletion was present in this region of the XMRV genome, which is not found in any known exogenous MuLV isolate. However, a shorter deletion of nine nt internal to this region is present in the sequences of several non-ecotropic MuLV proviruses found in the sequenced mouse genome (Figure 5). In cell culture, expression of intact glyco-Gag is not essential for viral replication [55,56]. However, lesions in this region have been associated with interesting variations in pathogenetic properties in vivo [57-61]. For example, an alteration in ten nt affecting five residues in the N-terminal peptide of glyco-Gag was found to be responsible for a 100-fold difference in the frequency of neuroinvasion observed between CasFrKP and CasFrKP41 MuLV strains [62]. In addition, insertion of an octanucleotide resulting in a stop codon downstream of the CUG start codon prevented severe early hemolytic anemia and prolonged latency of erythroleukemia in mice infected with Friend MuLV [58]. While we do not yet know the pathogenetic significance of the lesions in XMRV glyco-Gag, the high degree of sequence divergence suggests that this region may be under positive selective pressure and therefore may be relevant to the establishment of infection within the human host.
###end p 18
###begin title 19
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 15 19 <span type="species:ncbi:438045">XMRV</span>
Association of XMRV Infection and R462Q RNASEL Genotype
###end title 19
###begin p 20
###xml 90 96 90 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 265 274 265 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg001">Figure S1</xref>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 573 581 573 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g001">Figure 1</xref>
###xml 586 593 586 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0020025-t001">Table 1</xref>
###xml 696 704 696 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st003">Table S3</xref>
###xml 734 739 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 992 998 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 1055 1056 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 513 520 <span type="species:ncbi:9606">patient</span>
###xml 675 679 <span type="species:ncbi:438045">XMRV</span>
###xml 728 733 <span type="species:ncbi:10090">mouse</span>
###xml 880 885 <span type="species:ncbi:10090">mouse</span>
To further examine the association between presence of the virus and the R462Q (1385G->A) RNASEL genotype, we developed a specific nested RT-PCR assay based on the virus sequence recovered from one of the tumor samples (VP35, see above). The primers in this assay (Figure S1) amplify a 380-nt fragment from the divergent 5' leader and the N-terminal end of gag. The RT-PCR was positive in eight (40%) of 20 examined tumors from homozygous (QQ) individuals. In addition, one tumor from a homozygous wild-type (RR) patient was positive among 52 RR and 14 RQ tumors examined (Figure 1 and Table 1). Interestingly, this case was associated with the highest tumor grade among all XMRV-positive cases (Table S3). PCR specific for the mouse GAPDH gene was negative in all samples (unpublished data), arguing strongly against the possibility that the tumor samples were contaminated with mouse nucleic acid. Collectively, these data demonstrate a strong association between the homozygous (QQ) R462Q RNASEL genotype and presence of the virus in the tumor tissue (p < 0.00002 by two-tail Fisher's exact test).
###end p 20
###begin title 21
###xml 0 4 <span type="species:ncbi:438045">XMRV</span>
###xml 50 58 <span type="species:ncbi:9606">Patients</span>
XMRV Sequence Diversity in Samples from Different Patients
###end title 21
###begin p 22
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g006">Figure 6</xref>
###xml 540 551 540 551 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">M. musculus</named-content>
###xml 25 29 <span type="species:ncbi:438045">XMRV</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 485 489 <span type="species:ncbi:438045">XMRV</span>
###xml 540 551 <span type="species:ncbi:10090">M. musculus</span>
###xml 626 630 <span type="species:ncbi:438045">XMRV</span>
To examine the degree of XMRV sequence diversity in different patients, we sequenced the amplified fragments from all nine samples, which were positive by the nested gag RT-PCR. The amplified gag fragments were highly similar (Figure 6A) with >98% nt and >98% aa identity to each other. In contrast, the fragments had <89% nt and <95% aa identity with the most related exogenous sequence of MuLV DG-75. Several corresponding endogenous non-ecotropic sequences were more similar to the XMRV fragments, including the xenotropic provirus from M. musculus Chromosome 9, which was <98% identical on the nt level. Nevertheless, all XMRV-derived fragments were more similar to each other than they were to any other sequence.
###end p 22
###begin p 23
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 214 223 214 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg001">Figure S1</xref>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 305 313 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g006">Figure 6</xref>
###xml 508 511 508 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 55 62 <span type="species:ncbi:9606">patient</span>
###xml 495 499 <span type="species:ncbi:438045">XMRV</span>
In addition to the gag gene, we also examined the same patient samples for sequence variation in the pol gene. We sequenced PCR fragments obtained with a set of primers targeting a 2500-nt stretch in the pol gene (Figure S1). Similar to the gag fragments, the amplified pol fragments were highly similar (Figure 6B) and had >97% nt and >97% aa identity to each other. In contrast, the fragments had <94% nt and <95% aa identity with the most related sequence, that of MuLV DG-75. Interestingly, XMRV-derived pol sequences were less similar to and approximately equidistant from the examined representative xenotropic and polytropic endogenous sequences.
###end p 23
###begin p 24
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 57 65 57 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g006">Figure 6</xref>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 421 423 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b063">63</xref>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 514 517 514 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 570 574 <span type="species:ncbi:438045">XMRV</span>
###xml 708 716 <span type="species:ncbi:9606">patients</span>
###xml 785 789 <span type="species:ncbi:438045">XMRV</span>
Close clustering of the sequenced gag and pol fragments (Figure 6) indicates that all microarray and RT-PCR positive cases represent infection with the same virus. On the other hand, the degree of sequence variation in the examined fragments is higher than that expected from errors introduced during PCR amplification and sequencing. The frequency of nt misincorporation by Taq polymerase has been estimated as 10-6 - 10-4 ([63] and references therein), compared with the observed rate of up to 2% in the gag and pol fragments. These findings suggest that the observed XMRV sequence variation is a result of natural sequence diversity, consistent with the virus being independently acquired by the affected patients, and argue against laboratory contamination as a possible source of XMRV.
###end p 24
###begin title 25
###xml 13 17 <span type="species:ncbi:438045">XMRV</span>
Detection of XMRV in Tumor-Bearing Prostatic Tissues Using FISH
###end title 25
###begin p 26
###xml 476 484 476 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g007">Figure 7</xref>
###xml 681 689 681 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g008">Figure 8</xref>
###xml 735 743 735 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g008">Figure 8</xref>
###xml 816 824 816 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g008">Figure 8</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b064">64</xref>
###xml 1065 1073 1065 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g008">Figure 8</xref>
###xml 1140 1148 1140 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sv001">Video S1</xref>
###xml 1332 1340 1332 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g008">Figure 8</xref>
###xml 12 16 <span type="species:ncbi:438045">XMRV</span>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 101 105 <span type="species:ncbi:438045">XMRV</span>
###xml 305 309 <span type="species:ncbi:438045">XMRV</span>
###xml 330 337 <span type="species:ncbi:9606">patient</span>
###xml 438 442 <span type="species:ncbi:438045">XMRV</span>
###xml 828 832 <span type="species:ncbi:438045">XMRV</span>
###xml 957 961 <span type="species:ncbi:438045">XMRV</span>
###xml 1087 1091 <span type="species:ncbi:438045">XMRV</span>
To localize XMRV within human prostatic tissues, and to measure the frequency of the infected cells, XMRV nucleic acid was visualized using FISH on formalin-fixed prostate tissues. A SpectrumGreen fluorescently labeled FISH probe cocktail spanning all viral genes was prepared using cDNA derived from the XMRV isolate cloned from patient VP35 (Materials and Methods). Distinct FISH-positive cells were observed in the tumors positive for XMRV by RT-PCR (e.g., VP62 and VP88) (Figure 7). To identify cell types associated with the positive FISH signal, the same sections were subsequently stained with hematoxylin and eosin (H&E). Most FISH-positive cells were stromal fibroblasts (Figure 8A), including those undergoing cell division (Figure 8B). In addition, occasional infected hematopoietic cells were also seen (Figure 8C). XMRV FISH with concurrent immunostaining for cytokeratin AE1/AE3 to achieve specific labeling of epithelial cells [64] showed no XMRV-infected cells that also had the epithelium-specific staining, confirming their non-epithelial origin (Figure 8C). While the XMRV nucleic acid was usually present within nuclei (Video S1), suggesting integrated proviral DNA, some cells showed cytoplasmic staining adjacent to the nucleus, suggestive of viral mRNA and/or pre-integration complexes in non-dividing cells (Figure 8A).
###end p 26
###begin p 27
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0020025-t002">Table 2</xref>
###xml 754 757 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 807 814 807 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0020025-t002">Table 2</xref>
###xml 868 871 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 67 71 <span type="species:ncbi:438045">XMRV</span>
###xml 263 267 <span type="species:ncbi:438045">XMRV</span>
###xml 292 296 <span type="species:ncbi:438045">XMRV</span>
###xml 433 440 <span type="species:ncbi:9606">Patient</span>
###xml 542 546 <span type="species:ncbi:438045">XMRV</span>
###xml 1295 1299 <span type="species:ncbi:438045">XMRV</span>
###xml 1378 1382 <span type="species:ncbi:438045">XMRV</span>
###xml 1529 1533 <span type="species:ncbi:438045">XMRV</span>
###xml 1653 1661 <span type="species:ncbi:9606">patients</span>
We also used FISH to obtain a minimal estimate of the frequency of XMRV-infected prostatic cells. For this purpose we employed a tissue microarray containing duplicates of 14 different prostate cancer tissue specimens (Table 2). FISH with DNA probes derived from XMRV VP35 showed five to ten XMRV/FISH-positive cells (about 1% of prostate cells observed) in each of five homozygous RNase L 462Q (QQ) cases: VP29, 31, 42, 62, and 88. Patient sample VP79, also a QQ case, contained two positive cells (0.4% of total cells examined). All of the XMRV/FISH-positive cells observed were stromal cells. In contrast, three RR tissue samples and two RQ tissue samples showed one or no (<0.15%) FISH-positive cells. Two of the QQ cases, VP35 and VP90, positive by gag RT-PCR, showed only one FISH-positive cell each (Table 2). Conversely, one case, VP31, was FISH-positive, but gag-RT-PCR negative. As expected, Chromosome 1-specific probes used as a positive control specifically labeled nearly every cell from the examined case VP88, whereas a KSHV-specific probe used as a negative control did not label any cells in sections from cases VP88 and VP51, but did efficiently label 293T cells transfected with KSHV DNA (unpublished data). Thus, consistent with the microarray and RT-PCR data, detection of XMRV by FISH was associated primarily with QQ cases. In addition, in samples where XMRV was detected, all positive cells were stromal and did not account for more than 1% of all prostatic cells. Finally, differences in the numbers of XMRV-positive cells detected in the different samples could be due to heterogeneity in virus copy numbers between different patients and/or specific regions of the prostate sampled.
###end p 27
###begin title 28
###xml 13 17 <span type="species:ncbi:438045">XMRV</span>
Detection of XMRV in Tumor-Bearing Prostatic Tissues Using IHC
###end title 28
###begin p 29
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b065">65</xref>
###xml 391 399 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">Figure 9</xref>
###xml 520 528 520 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">Figure 9</xref>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">9</xref>
###xml 558 566 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">Figure 9</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">9</xref>
###xml 726 734 726 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">Figure 9</xref>
###xml 858 866 858 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g009">Figure 9</xref>
###xml 29 33 <span type="species:ncbi:438045">XMRV</span>
###xml 124 128 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 347 351 <span type="species:ncbi:438045">XMRV</span>
To identify cells expressing XMRV proteins, we assayed for the presence of Gag protein using a monoclonal antibody against (SFFV); this antibody is reactive against Gag proteins from a wide range of different ecotropic, polytropic, and xenotropic MuLV strains [65]. Using this antibody, positive signal by IHC was observed in prostatic tissues of XMRV-positive cases VP62 and VP88, both QQ (Figure 9). An enhanced alkaline phosphatase red detection method allowed Gag detection in the same cells with both fluorescence (Figure 9A-9D, left) and bright field (Figure 9A-9D, middle) microscopy. The Gag-expressing cells were observed in prostatic stromal cells with a distribution and frequency similar to that detected by FISH (Figure 9 and unpublished data). In contrast, no Gag-positive cells were observed in VP51 prostatic tissue, which is of RR genotype (Figure 9E).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 36 40 <span type="species:ncbi:438045">XMRV</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 262 266 <span type="species:ncbi:438045">XMRV</span>
###xml 370 378 <span type="species:ncbi:9606">patients</span>
###xml 400 404 <span type="species:ncbi:438045">XMRV</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 465 469 <span type="species:ncbi:438045">XMRV</span>
The results presented here identify XMRV infection in prostate tissue from approximately 40% of patients with prostate cancer who are homozygous for the R462Q variant (QQ) of RNase L, as judged by both hybridization to the Virochip microarray and by RT-PCR with XMRV-specific primers. Parallel RT-PCR studies of prostate tumors from wild-type (RR) and heterozygous (RQ) patients revealed evidence of XMRV in only one of 66 samples, clearly demonstrating that human XMRV infection is strongly linked to decrements in RNase L activity. This result supports the view that the R462Q RNase L variant leads to a subtle defect in innate (IFN-dependent) antiviral immunity.
###end p 31
###begin p 32
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b049">49</xref>
###xml 587 589 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b066">66</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b049">49</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b067">67</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b069">69</xref>
###xml 1114 1116 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b038">38</xref>
###xml 1117 1119 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b040">40</xref>
###xml 23 27 <span type="species:ncbi:438045">XMRV</span>
###xml 61 84 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 356 361 <span type="species:ncbi:10090">mouse</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 723 728 <span type="species:ncbi:10090">mouse</span>
###xml 872 877 <span type="species:ncbi:10090">mouse</span>
###xml 882 885 <span type="species:ncbi:10116">rat</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1051 1057 <span type="species:ncbi:10090">murine</span>
###xml 1219 1225 <span type="species:ncbi:9606">humans</span>
As its name indicates, XMRV is closely related to xenotropic murine leukemia viruses (MuLVs). Unlike ecotropic MuLVs, such as the canonical Moloney MuLV, which grow only in rodent cells in culture, xenotropic MuLVs can grow in non-rodent cells in culture but not in rodent cell lines. Xenotropic viruses have been isolated from many inbred as well as wild mouse strains. Studies of the distribution of non-ecotropic sequences in different mouse strains show that the diversity of xenotropic proviral sequences in wild mice is greater than that found in the inbred laboratory strains [49,66]. This finding led to the conclusion that these endogenous elements were independently and relatively recently acquired by different mouse species as a result of infection rather than inheritance [49]. Unlike ecotropic MuLVs, which can only recognize a receptor (CAT-1) specific to mouse and rat species [67-69], xenotropic viruses recognize a protein known as XPR1 or SYG1. XPR1 is expressed in all higher vertebrates, including mice, but polymorphisms in the murine gene render it unable to mediate xenotropic MuLV entry [38-40]. Thus, xenotropic MuLVs have a potential to infect a wide variety of mammalian species, including humans.
###end p 32
###begin p 33
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b024">24</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b032">32</xref>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 348 357 <span type="species:ncbi:10090">nude mice</span>
###xml 504 508 <span type="species:ncbi:438045">XMRV</span>
###xml 533 538 <span type="species:ncbi:9606">human</span>
###xml 556 562 <span type="species:ncbi:10090">murine</span>
###xml 678 683 <span type="species:ncbi:9606">human</span>
###xml 758 762 <span type="species:ncbi:438045">XMRV</span>
###xml 795 803 <span type="species:ncbi:9606">patients</span>
###xml 1135 1139 <span type="species:ncbi:438045">XMRV</span>
###xml 1271 1277 <span type="species:ncbi:9606">humans</span>
###xml 1356 1360 <span type="species:ncbi:438045">XMRV</span>
###xml 1583 1587 <span type="species:ncbi:438045">XMRV</span>
###xml 1601 1607 <span type="species:ncbi:9606">humans</span>
Xenotropic MuLVs have occasionally been detected in cultured human cell lines. For example, MuLV DG-75 was cloned from a human B-lymphoblastoid cell line [24], and an infectious xenotropic MuLV was detected in a human small cell lung cancer line NCI-417 [32]. Although laboratory contamination, either in culture or during passage of cell lines in nude mice, cannot be ruled out as a possible source in these cases, such contamination cannot explain our results. The evidence for this is as follows: (i) XMRV was detected in primary human tissues; (ii) no murine sequences (e.g., GAPDH) could be detected in our materials by PCR; (iii) infection was predominantly restricted to human samples with the QQ RNASEL genotype; (iv) polymorphisms were found in the XMRV clones recovered from different patients consistent with independent acquisition of the virus by these individuals; and (v) viral nucleic acids and antigens could be detected in infected QQ prostate tissue by FISH and IHC, respectively. Taken together, the above evidence argues strongly against laboratory contamination with virus or cloned DNA material as the source of XMRV infection in the analyzed samples. To our knowledge, this report represents the first published examples of authentic infection of humans with a xenotropic MuLV-like agent. Although our efforts to clone the sites of XMRV integration into the host genome have been limited by the small amounts of prostate tissue available for this purpose, our work to clone such sites is ongoing and will provide an important additional piece of evidence for XMRV infection in humans.
###end p 33
###begin p 34
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b070">70</xref>
###xml 626 632 626 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 4 8 <span type="species:ncbi:438045">XMRV</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 234 238 <span type="species:ncbi:438045">XMRV</span>
###xml 267 271 <span type="species:ncbi:438045">XMRV</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 910 914 <span type="species:ncbi:438045">XMRV</span>
###xml 1093 1097 <span type="species:ncbi:438045">XMRV</span>
###xml 1181 1185 <span type="species:ncbi:10090">mice</span>
###xml 1189 1193 <span type="species:ncbi:10116">rats</span>
###xml 1239 1243 <span type="species:ncbi:438045">XMRV</span>
###xml 1299 1305 <span type="species:ncbi:9606">humans</span>
###xml 1318 1322 <span type="species:ncbi:438045">XMRV</span>
###xml 1353 1358 <span type="species:ncbi:9606">human</span>
###xml 1729 1735 <span type="species:ncbi:9606">humans</span>
###xml 1737 1741 <span type="species:ncbi:438045">XMRV</span>
The XMRV sequence is not found in human genomic DNA, and none of the human endogenous retroviruses, including the only known gammaretrovirus-like human endogenous sequences (hERVs E and T) [70], bare any significant similarity to the XMRV genome. This indicates that XMRV must have been acquired exogenously by infection in positive subjects. From what reservoir and by what route such infections were acquired is unknown. It seems unlikely that direct contact with feral mice could explain the observed distribution of infection in our cohort, since there is no reason to believe that rodent exposure would vary according to RNASEL genotype. It is possible that infection is more widespread than indicated by the present studies, especially if, as seems likely, individuals with the wild-type RNase L clear infection more promptly than those with the QQ genotype. But if so, a cross-species transfer model of XMRV infection would require improbably high levels of rodent exposure for a developed society like our own. Thus, although the viral sequence suggests that the ultimate reservoir of XMRV is probably the rodent, the proximate source of the infection seems unlikely to be mice or rats. Provisionally, we favor the notion that the XMRV infections we have documented were acquired from other humans, i.e., that XMRV may have been resident in the human population for some time. This speculation will, however, require direct epidemiologic validation. It also remains to be determined if RNase L R462Q homozygotes are more sensitive to the acquisition of infection, or are simply less likely to clear infection once acquired. This is an important issue, since if the latter model is correct, it would imply that in younger humans, XMRV prevalence may be higher than what is observed in our prostate cancer cohort (mean age 58.7 y). We are currently developing serologic assays for use in population-based studies that should shed light on these matters.
###end p 34
###begin p 35
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b071">71</xref>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b072">72</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b073">73</xref>
###xml 47 51 <span type="species:ncbi:438045">XMRV</span>
###xml 220 224 <span type="species:ncbi:438045">XMRV</span>
###xml 313 317 <span type="species:ncbi:438045">XMRV</span>
###xml 1044 1049 <span type="species:ncbi:9606">human</span>
###xml 1140 1144 <span type="species:ncbi:438045">XMRV</span>
###xml 1442 1446 <span type="species:ncbi:438045">XMRV</span>
While presented work documents a clear link of XMRV infection to RNase L deficiency, we emphasize that the data we have accumulated does not mandate any etiological link to prostate cancer. Furthermore, our finding that XMRV infection is targeted to stromal cells and not to carcinoma cells and the fact that the XMRV genome harbors no host-derived oncogenes rule out two classical models for retroviral oncogenesis: direct introduction of a dominantly acting oncogene and insertional activation of such a gene. However, more indirect contributions of the virus to the tumor can certainly be envisioned. Recent work has shown that stromal cells have an active role in directly promoting tumorigenesis of adjacent epithelial cells by producing various cytokines and growth factors that serve as proliferative signals [71] or indirectly by modifying the tumor microenvironment by promotion of angiogenesis or recruitment of inflammatory mediators leading to oxidative stress [72]. In particular, cancer-associated fibroblasts stimulate growth of human prostatic epithelial cells and alter their histology in vivo [73]. It is conceivable that XMRV-infected prostatic stromal cells could produce and secrete growth factors, cytokines or other factors that stimulate cell proliferation or promote oxidative stress in surrounding epithelia. Such a paracrine mechanism could still function quite efficiently even with the relatively small number of XMRV-infected cells that characterize the lesion.
###end p 35
###begin p 36
###xml 444 450 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 75 79 <span type="species:ncbi:438045">XMRV</span>
###xml 384 388 <span type="species:ncbi:438045">XMRV</span>
Finally, we note that the identification of an exogenous infection such as XMRV could help explain why not all genetic studies have consistently identified RNase L as a prostate cancer susceptibility factor. If such an infection were linked, however indirectly, to prostate cancer risk, and if the prevalence of infection is not uniform in different populations, populations with low XMRV prevalence might be expected to show no association of RNASEL lesions to prostate cancer.
###end p 36
###begin p 37
###xml 116 120 <span type="species:ncbi:438045">XMRV</span>
Clearly, resolution of these issues will require much further investigation. We need to determine the prevalence of XMRV infection in the general population, understand its routes of transmission and tissue tropism, explore its associations with pre-maligant and other prostatic conditions, and define the biochemical interactions of the virus with the 2-5A/RNase L system. The availability of molecular clones, infectious virus stocks, and susceptible cell culture systems should greatly enhance our ability to probe these and other questions in the near future.
###end p 37
###begin title 38
Materials and Methods
###end title 38
###begin title 39
###xml 14 22 <span type="species:ncbi:9606">patients</span>
Genotyping of patients, and prostate tissue processing.
###end title 39
###begin p 40
###xml 245 253 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st003">Table S3</xref>
###xml 360 366 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 2065 2066 2035 2036 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 193 197 <span type="species:ncbi:438045">XMRV</span>
###xml 255 258 <span type="species:ncbi:9606">Men</span>
All human samples used in this study were obtained according to protocols approved by the Cleveland Clinic's Institutional Review Board. Age, clinical parameters, and geographical locations of XMRV-positive prostate cancer cases are provided in Table S3. Men scheduled to undergo prostatectomies at the Cleveland Clinic were genotyped for the R462Q (1385G->A) RNASEL variant using a premade TAQMAN genotyping assay (Applied Biosystems, Foster City, California, United States; Assay c_935391_1) on DNA isolated from peripheral blood mononuclear cells. Five nanograms of genomic DNA were assayed according to the manufacturer's instructions, and analyzed on an Applied Biosystems 7900HT Sequence Detection System instrument. Immediately after prostatectomies, tissue cores were taken from both the transitional zone (the site of benign prostatic hyperplasia, BPH) and the peripheral zone (where cancer generally occurs), snap-frozen in liquid nitrogen, and then stored at -80 degreesC. Remaining prostate tissue was fixed in 10% neutral buffered formalin, processed, and embedded in paraffin for later histological analyses. Frozen tissue cores were transferred from dry ice immediately to TRIZOL reagent (Invitrogen, Carlsbad, California, United States), homogenized with a power homogenizer or manually using a scalpel followed by a syringe, and total RNA was isolated according to the manufacturer's instructions. The prostate tissue RNA was then subjected to RNase-free DNase I (Ambion, Austin, Texas, United States) digestion for 30 min at 37 degreesC. The sample was then extracted with phenol and the RNA was precipitated with isopropanol overnight at -20 degreesC followed by centrifugation at 12,000 g for 30 min at 4 degreesC. Poly-A RNA was isolated from the DNase digested total RNA using the Oligotex mRNA Midi Kit (Qiagen USA, Valencia, California, United States) as instructed by the manufacturer. The poly-A RNA concentration was measured using the RIBOgreen quantitation kit (Molecular Probes, Invitrogen), and the samples were stored at -80 degreesC.
###end p 40
###begin title 41
Microarray screening.
###end title 41
###begin p 42
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b020">20</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b022">22</xref>
###xml 260 271 260 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sd001">Protocol S1</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b021">21</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b022">22</xref>
###xml 602 610 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st001">Table S1</xref>
###xml 621 629 621 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g001">Figure 1</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b074">74</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b075">75</xref>
Virochip microarrays used in this study were identical to those previously described [20-22]. Prostate tumor RNA samples were amplified and labeled using a modified Round A/B random PCR method and hybridized to the Virochip microarrays as reported previously (Protocol S1 in [21]). Microarrays were scanned with an Axon 4000B scanner (Axon Instruments, Union City, California, United States) and gridded using the bundled GenePix 3.0 software. Microarray data have been submitted to the NCBI GEO database (GSE3607). Hybridization patterns were interpreted using E-Predict as previously described [22] (Table S1). To make Figure 1, background-subtracted hybridization intensities of all retroviral oligonucleotides (205) were used to cluster samples and the oligonucleotides. Average linkage hierarchical clustering with Pearson correlation as the similarity metric was carried out using Cluster (version 2.0) [74]. Cluster images were generated using Java TreeView (version 1.0.8) [75].
###end p 42
###begin title 43
Genome cloning and sequencing.
###end title 43
###begin p 44
###xml 809 820 809 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sd001">Protocol S1</xref>
###xml 1306 1314 1300 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g002">Figure 2</xref>
###xml 459 463 <span type="species:ncbi:11819?1.0">SFFV</span>
Amplified and labeled cDNA from the VP35 tumor sample was hybridized to a hand-spotted microarray containing several retroviral oligonucleotides, which had high hybridization intensity on the Virochip during the initial microarray screening. Nucleic acid hybridizing to two of the oligonucleotides (9628654_317_rc derived from MTCR: TTC GCT TTA TCT GAG TAC CAT CTG TTC TTG GCC CTG AGC CGG GGC CCA GGT GCT CGA CCA CAG ATA TCC T; and 9626955_16_rc derived from SFFV: TCG GAT GCA ATC AGC AAG AGG CTT TAT TGG GAA CAC GGG TAC CCG GGC GAC TCA GTC TGT CGG AGG ACT G) was then individually eluted off the surface of the spots and amplified by PCR with Round B primers. Preparation of the hand-spotted array, hybridization, probe recovery, and PCR amplification of the recovered material were carried out according to Protocol S1. The recovered amplified DNA samples were then cloned into pCR2.1-TOPO TA vector (Invitrogen), and the resulting libraries were screened by colony hybridization with the corresponding above oligonucleotides as probes. Hybridizations were carried out using Rapid-Hyb buffer (Amersham, Piscataway, New Jersey, United States) according to the manufacturer's protocol at 50 degreesC for 4 h. Eight positive clones were sequenced, of which two (one from each library; clones K1 and K2R1 in Figure 2A) were viral and had 94-95% nt identity to MTCR.
###end p 44
###begin p 45
###xml 531 539 531 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st002">Table S2</xref>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b076">76</xref>
###xml 369 373 <span type="species:ncbi:438045">XMRV</span>
To sequence the remainder of the VP35 genome as well as the entire genome from the VP42 tumor, we amplified fragments of the genome by PCR using either amplified (Round B) or unamplified (Round A) cDNA prepared for original Virochip screening. This was accomplished first using a combination of primers derived from the sequence of MTCR and earlier recovered clones of XMRV. The two overlapping fragments from VP62 were amplified by PCR from cDNA generated by priming poly-A RNA with random hexamers. All PCR primers are listed in Table S2. The amplified fragments were cloned into pCR2.1-TOPO TA vector (Invitrogen) and sequenced using M13 sequencing primers. Genome assembly was carried out using CONSED version 13.84 for Linux [76].
###end p 45
###begin title 46
PCR.
###end title 46
###begin p 47
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 77 88 77 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sd002">Protocol S2</xref>
Screening of tumor samples by gag nested RT-PCR was carried out according to Protocol S2. PCR fragments in all positive cases were gel-purified using QIAEX II gel extraction kit (Qiagen), cloned into pCR2.1-TOPO TA vector (Invitrogen), and sequenced using M13 sequencing primers.
###end p 47
###begin p 48
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pol</italic>
Pol PCR was carried out using amplified cDNA (Round B material) as the template.
###end p 48
###begin p 49
###xml 93 101 93 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st002">Table S2</xref>
Sequence of the primers used for amplification (2670F, 3870R, 3810F, and 5190R) is listed in Table S2. Amplified products were gel-purified using QIAEX II gel extraction kit (Qiagen), and purified products were directly used for sequencing.
###end p 49
###begin title 50
Phylogenetic analyses.
###end title 50
###begin p 51
###xml 290 299 290 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-sg002">Figure S2</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b077">77</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b077">77</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b049">49</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b048">48</xref>
###xml 162 166 <span type="species:ncbi:438045">XMRV</span>
Xenotropic mERV Chromosome 1, xenotropic mERV Chromosome 4, and xenotropic mERV Chromosome 9 were chosen by BLAST querying the NCBI nr database with the complete XMRV genomes and selecting the most similar full-length proviral sequences, all of which happened to have xenotropic envelopes (Figure S2C). Polytropic mERV Chromosome 7 and polytropic mERV Chromosome 11 were chosen by selecting NCBI nr full-length proviral sequences with envelopes most similar to a prototype polytropic clone MX27 [77]. Similarly, modified polytropic mERV Chromosome 7 and modified polytropic mERV Chromosome 12 were selected on the basis of similarity to a prototype-modified polytropic clone MX33 [77]. U3 analysis was performed using previously described reference sequences: Mcv18, Mcv3, Mxv2, Mcv11, Mxv11, and HEMV18 [49]; CWM-T-15, CWM-T-15-4, CWM-T-25a, and CWM-T-25b [48].
###end p 51
###begin p 52
###xml 69 77 69 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g003">Figure 3</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b078">78</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b079">79</xref>
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b080">80</xref>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
To generate the neighbor-joining tree of complete genomic sequences (Figure 3), the sequences were first manually edited to make all genomes the same length, i.e., R to R. The edited sequences were then aligned with ClustalX version 1.82 for Linux [78,79] using default settings. The tree was generated based on positions without gaps only; Kimura correction for multiple base substitutions [80] and bootstrapping with n = 1000 were also used.
###end p 52
###begin p 53
All other trees were generated as above, except sequences were first trimmed to the same length, gaps were included, and Kimura correction was not used, as using these parameters did not have any significant effect on the trees.
###end p 53
###begin title 54
Antibodies.
###end title 54
###begin p 55
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b065">65</xref>
###xml 23 27 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 715 719 <span type="species:ncbi:438045">XMRV</span>
###xml 778 783 <span type="species:ncbi:10090">mouse</span>
Monoclonal antibody to SFFV Gag protein was produced from R187 cells ([65]; ATCC: CRL-1912) grown in DMEM (Media Core, Cleveland Clinic Foundation, Cleveland, Ohio, United States) with 10% ultra-low IgG FBS (Invitrogen) until confluent. Conditioned media was collected every three days from confluent cultures. Five ml of conditioned media per preparation was centrifuged at 168 x g for 5 min at 4 degreesC. Supernatant was filtered through a 0.22-mum syringe filter unit (Millipore, Billerica, Massachusetts, United States) and concentrated 16-fold in an Amicon ultrafiltration unit with a 100-kDa molecular weight cutoff membrane (Millipore). Sodium azide was added to a final concentration of 0.02%. Concomitant XMRV FISH/cytokeratin immunofluorescence was performed using a mouse anti-cytokeratin AE1/AE3 (20:1 mixture) monoclonal antibody (Chemicon International, Temecula, California, United States) capable of recognizing normal and neoplastic cells of epithelial origin.
###end p 55
###begin title 56
FISH.
###end title 56
###begin p 57
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 1071 1072 1064 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 8 <span type="species:ncbi:438045">XMRV</span>
###xml 1495 1500 <span type="species:ncbi:9606">human</span>
###xml 1932 1936 <span type="species:ncbi:438045">XMRV</span>
The XMRV-35 FISH probe cocktail was generated using both 2.15-kb and 1.84-kb segments of the viral genome obtained by PCR with forward primer-2345, 5' ACC CCT AAG TGA CAA GTC TG 3' with reverse primer-4495, 5' CTG GAC AGT GAA TTA TAC TA 3' and forward primer-4915, 5' AAA TTG GGG CAG GGG TGC GA 3' with reverse primer-6755, 5' TTG GAG TAA GTA CCT AGG AC 3', both cloned into pGEM-T (Promega, Madison, Wisconsin, United States). The recombinant vectors were digested with EcoRI to release the viral cDNA fragments, which were purified after gel electrophoresis (Qiagen). The purified viral cDNA inserts were used in nick translation reactions to produce SpectrumGreen dUTP fluorescently labeled probe according to manufacturer's instructions (Vysis Inc., Des Plaines, Illinois, United States). Freshly baked slides of prostatic tissues or tissue microarray arrays with ~4-mum thick tissue sections were deparaffinized, rehydrated, and subjected to Target Retrieval (Dako, Glostrup, Denmark) for 40 min at 95 degreesC. Slides were cooled to room temperature and rinsed in H2O. Proteinase K (Dako) at 1:5000 in Tris-HCl (pH 7.4) was applied directly to slides for 10 min at room temperature. Adjacent tissue sections were also probed with SpectrumGreen dUTP fluorescently labeled KSHV-8 DNA (nts 85820-92789) as a negative control or, as a positive control with SpectrumGreen and SpectrumOrange labeled TelVysion DNA Probe cocktail (Vysis), specific for subtelomeric regions of the P and Q arms of human Chromosome 1 as a positive control to ensure the tissue was completely accessible to FISH. FISH slides were examined using a Leica DMR microscope (Leica Micro-Systems, Heidelberg, Germany), equipped with a Retiga EX CCD camera (Q-Imaging,Vancouver, British Columbia, Canada). FISH images were captured using a Leica TCS SP2 laser scanning confocal with a 63x oil objective numerical aperature 1.4 (Leica Micro-Systems) microscope. XMRV nucleic acids were visualized using maximum intensity projections of optical slices acquired using a 488-nm argon-laser (emission at 500-550 nm). TelVysion DNA Probes were visualized using maximum intensity projections of optical slices acquired using a 488-nm argonlaser (emission at 500-550 nm) and 568-nm krypton-argon-laser (emission at 575-680 nm). DAPI was visualized using maximum intensity projections of optical slices acquired using a 364-nm UV-laser (emission at 400-500 nm). Slides were subsequently washed in 2x SSC (0.3 M sodium chloride and 0.03 M sodium citrate, [pH 7.0]) to remove coverslips, and H&E stained for morphological evaluation.
###end p 57
###begin title 58
IHC.
###end title 58
###begin p 59
###xml 7 12 <span type="species:ncbi:9606">human</span>
###xml 421 425 <span type="species:ncbi:11819?1.0">SFFV</span>
###xml 703 707 <span type="species:ncbi:9925">Goat</span>
###xml 713 716 <span type="species:ncbi:10116">Rat</span>
IHC on human tissues was performed on a Benchmark Ventana Autostainer (Ventana Medical Systems, Tucson, Arizona, United States). Unstained, formalin-fixed, paraffin-embedded prostate sections were placed on electrostatically charged slides and deparaffinized followed by a mild cell conditioning achieved through the use of Cell Conditioner #2 (Ventana Medical Systems). The concentrated R187 monoclonal antibody against SFFV p30 Gag was dispensed manually onto the sections at 10 mug per ml and allowed to incubate for 32 min at 37 degreesC. Endogenous biotin was blocked in sections using the Endogenous Biotin Blocking Kit (Ventana Medical Systems). Sections were washed, and biotinylated ImmunoPure Goat Anti-Rat IgG (Pierce Biotechnology, Rockford, Illinois, United States) was applied at a concentration of 4.8 mug per ml for 8 min. To detect Gag protein localization, the Ventana Enhanced Alkaline Phosphatase Red Detection Kit (Ventana Medical Systems) was used. Sections were briefly washed in distilled water and counterstained with Hematoxylin II (Ventana Medical Systems) for approximately 6 min. Sections were washed, dehydrated in graded alcohols, incubated in xylene for 5 min, and coverslips were added with Cytoseal (Microm International, Walldorf, Germany). Negative controls were performed as above except without the addition of the R187 monoclonal antibody.
###end p 59
###begin p 60
###xml 681 682 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 683 684 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 12 16 <span type="species:ncbi:438045">XMRV</span>
###xml 86 93 <span type="species:ncbi:9606">patient</span>
###xml 962 966 <span type="species:ncbi:9925">Goat</span>
###xml 972 977 <span type="species:ncbi:10090">mouse</span>
###xml 982 993 <span type="species:ncbi:3704">horseradish</span>
###xml 1337 1341 <span type="species:ncbi:438045">XMRV</span>
Concomitant XMRV FISH/cytokeratin IHC was performed on slides of prostate tissue from patient VP62. First, sections were immunostained for cytokeratin AE1/AE3 using the Alexa Fluor 594 Tyramide Signal Amplification Kit (Molecular Probes, Invitrogen). Briefly, unstained, formalin-fixed, paraffin-embedded sections cut at ~4 mum were placed on electrostatically charged slides, baked at 65 degreesC for at least 4 h, deparaffinized in xylene, and rehydrated through decreasing alcohol concentrations. Slides were incubated in Protease II (Ventana Medical Systems) for 3 min at room temperature and washed in phosphate-buffered saline (PBS) in peroxidase quenching buffer (PBS + 3% H2O2) for 60 min at room temperature, then incubated with 1% blocking reagent (10 mg/ml BSA in PBS) for 60 min at room temperature. The slides were incubated with cytokeratin AE1/AE3 antibody diluted in 1% blocking reagent for 60 min at room temperature and rinsed 3x times in PBS. Goat anti-mouse IgG-horseradish peroxidase (Molecular Probes, Invitrogen) was added and incubated for 60 min at room temperature. The slides were rinsed 3x in PBS. The tyramide solution was added to the slides for 10 min at room temperature and the slides were rinsed 3x in PBS. Slides were then placed in Target Retrieval solution (Dako) for 40 min at 95 degreesC. FISH for XMRV was performed as described above except in the absence of proteinase K treatment. After FISH, the slides were mounted with Vectashield Mounting Medium plus DAPI (Vector Labs, Burlingame, California, United States) and examined using fluorescence microscopy. Immunofluorescence images were captured using a Texas red filter with a Leica DMR microscope (Leica Micro-Systems), equipped with a Retiga EX CCD camera (QImaging).
###end p 60
###begin title 61
Supporting Information
###end title 61
###begin title 62
###xml 32 36 <span type="species:ncbi:438045">XMRV</span>
Complete Nucleotide Sequence of XMRV VP35
###end title 62
###begin p 63
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 104 107 <span type="species:ncbi:103820">Gag</span>
###xml 109 112 <span type="species:ncbi:103820">Gag</span>
Numbers to the left indicate nt coordinates relative to the first nt. Predicted open reading frames for Gag, Gag-Pro-Pol, and Env polyproteins are shown below the corresponding nt. Characteristic 24-nt deletion in the 5' gag leader is indicated with a triangle. Other genome features as well as primers used in the nested gag RT-PCR are shown as arrows.
###end p 63
###begin p 64
(558 KB PDF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin title 66
###xml 25 29 <span type="species:ncbi:438045">XMRV</span>
Phylogenetic Analysis of XMRV Based on Predicted Gag, Pro-Pol, and Env Polyproteins
###end title 66
###begin p 67
###xml 459 480 459 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 57 61 <span type="species:ncbi:438045">XMRV</span>
###xml 197 218 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 220 223 <span type="species:ncbi:11768">FLV</span>
###xml 226 242 <span type="species:ncbi:394239">koala retrovirus</span>
###xml 244 248 <span type="species:ncbi:394239">KoRV</span>
###xml 251 276 <span type="species:ncbi:11840">gibbon ape leukemia virus</span>
###xml 278 282 <span type="species:ncbi:11840">GALV</span>
Predicted Gag (A), Pro-Pol (B), and Env (C) sequences of XMRV VP35, VP42, and VP62 (red) as well as the corresponding sequences from MTCR; MuLVs DG-75, MCF1233, Akv, Moloney, Friend, and Rauscher; feline leukemia virus (FLV); koala retrovirus (KoRV); gibbon ape leukemia virus (GALV), and a set of representative non-ecotropic proviruses (mERVs) were aligned using ClustalX. The resulting alignments were used to generate unrooted neighbor-joining trees (see Materials and Methods). Sequences are labeled as xenotropic (X), polytropic (P), modified polytropic (Pm), or ecotropic (E).
###end p 67
###begin p 68
(186 KB EPS)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin title 70
###xml 14 18 <span type="species:ncbi:438045">XMRV</span>
Comparison of XMRV U3 Region to Representative Non-Ecotropic Sequences
###end title 70
###begin p 71
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b037">37</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b048">48</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b049">49</xref>
###xml 216 237 216 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b037">37</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b049">49</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b037">37</xref>
###xml 53 57 <span type="species:ncbi:438045">XMRV</span>
###xml 271 275 <span type="species:ncbi:438045">XMRV</span>
###xml 531 535 <span type="species:ncbi:438045">XMRV</span>
###xml 627 631 <span type="species:ncbi:438045">XMRV</span>
(A) Multiple sequence alignment of U3 sequences from XMRV VP35, VP42, and VP62; MuLVs NZB-9-1 and NFS-Th-1; and from representative non-ecotropic proviruses [37,48,49]. The sequences were aligned using ClustalX (see Materials and Methods). Only sequences most similar to XMRV are shown. Glucocorticoid response element (GRE), and TATA and CAT boxes are indicated by lines. Direct repeat regions (boxed) are numbered according to the existing convention [37,49]. Triangle indicates a 190 nt insertion in polytropic proviruses [37]. XMRV-specific AG dinucleotide insertion is shown in red. Dots denote nt identical to those from XMRV, and deleted nt appear as spaces.
###end p 71
###begin p 72
###xml 145 166 145 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 248 252 <span type="species:ncbi:438045">XMRV</span>
(B) Phylogenetic tree based on U3 nt sequences. Multiple sequence alignment from (A) was used to generate an unrooted neighbor-joining tree (see Materials and Methods). Bootstrap values (n = 1000 trials) are shown as percentages. U3 sequences from XMRV are shown in red.
###end p 72
###begin p 73
(188 KB EPS)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin title 75
Probe Recovery from Hand-Spotted Microarrays by "Scratching"
###end title 75
###begin p 76
(83 KB PDF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin title 78
###xml 5 8 5 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 0 4 <span type="species:ncbi:438045">XMRV</span>
XMRV gag Nested RT-PCR
###end title 78
###begin p 79
(172 KB PDF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin title 81
###xml 94 102 94 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g001">Figure 1</xref>
Computational Viral Species Predictions Using E-Predict for the Virochip Microarrays Shown in Figure 1
###end title 81
###begin p 82
(48 KB DOC)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin title 84
###xml 35 39 <span type="species:ncbi:438045">XMRV</span>
PCR Primers Used for Sequencing of XMRV Genomes
###end title 84
###begin p 85
(45 KB DOC)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin title 87
###xml 56 60 <span type="species:ncbi:438045">XMRV</span>
Age, Clinical Parameters, and Geographical Locations of XMRV-Positive Prostate Cancer Cases
###end title 87
###begin p 88
(39 KB DOC)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin title 90
###xml 50 54 <span type="species:ncbi:438045">XMRV</span>
Confocal Optical Image Planes of a Representative XMRV FISH Positive Cell
###end title 90
###begin p 91
###xml 77 85 76 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0020025-g001">Figure 1</xref>
###xml 48 52 <span type="species:ncbi:438045">XMRV</span>
###xml 486 490 <span type="species:ncbi:438045">XMRV</span>
Optical image planes (0.5 mum step-size) of the XMRV FISH positive cell from Figure 1A acquired using a Leica TCS SP2 laser scanning spectral confocal microscope (Leica, Heidelberg, Germany) were reconstructed into a 3D volume set using Volocity 3.5 (Improvision, Lexington, Massachusetts, United States). Using Volocity's movie sequence editor, each volume was rotated along horizontal and vertical axes, adjusting nuclei stained DAPI (blue) channel brightness to visualize underlying XMRV FISH (green) nucleic acid signal. The resulting image frames were exported as a movie sequence. Underlying grid represents glass slide to which tissue was placed for FISH analysis. Each square unit within grid represents 4 mum in height and width.
###end p 91
###begin p 92
(237 KB WMV)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin title 94
Accession Numbers
###end title 94
###begin p 95
###xml 59 80 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 119 144 <span type="species:ncbi:11840">gibbon ape leukemia virus</span>
###xml 158 174 <span type="species:ncbi:394239">koala retrovirus</span>
###xml 818 822 <span type="species:ncbi:438045">XMRV</span>
###xml 840 844 <span type="species:ncbi:438045">XMRV</span>
###xml 866 870 <span type="species:ncbi:438045">XMRV</span>
Accession numbers from Gen Bank () are: AKV MuLV (J01998), feline leukemia virus (NC_001940), Friend MuLV (NC_001372), gibbon ape leukemia virus (NC_001885), koala retrovirus (AF151794), modified polytropic mERV Chromosome 7 (AC127565; nt 64,355-72,720), modified polytropic mERV Chromosome 12 (AC153658; nt 85,452-93,817), Moloney MuLV (NC_001501), MTCR (NC_001702MuLV DG-75 (AF221065); MuLV MCF 1233 (U13766), MuLV NCI-417 (AAC97875), MuLV NZB-9-1 (K02730), polytropic mERV Chromosome 7 (AC167978; nt 57,453-65,805), polytropic mERV Chromosome 11 (168-229,176,580), prototype polytropic clone MX27 (M17327), Rauscher MuLV (NC_001819), xenotropic mERV Chromosome 1 (AC083892, nt 158,240-166,448), xenotropic mERV Chromosome 4 (AL627077; nt 146,400-154,635), xenotropic mERV Chromosome 9 (AC121813; nt 37,520-45,770), XMRV VP35 (DQ241301), XMRV VP42 (DQ241302), and XMRV VP 62 (DQ399707).
###end p 95
###begin p 96
We thank Silvi Rouskin, Shoshannah Beck, James Pettay, and Jayashree Paranjape for expert technical assistance; Sanggu Kim and Samson A. Chow for technical advice; Earl Poptic for production and purification of monoclonal antibodies to Gag; Stephen T. Koury for advice; and Judith A. Drazba and Amit Vasanji for assistance with confocal imaging.
###end p 96
###begin title 97
Abbreviations
###end title 97
###begin p 98
5'-phosphorylated 2'-5' oligoadenylate
###end p 98
###begin p 99
amino acid
###end p 99
###begin p 100
fluorescence in situ hybridization
###end p 100
###begin p 101
hematoxylin and eosin
###end p 101
###begin p 102
hereditary prostate cancer
###end p 102
###begin p 103
interferon
###end p 103
###begin p 104
immunohistochemistry
###end p 104
###begin p 105
long terminal repeat
###end p 105
###begin p 106
###xml 0 4 <span type="species:ncbi:452646|species:ncbi:9666">mink</span>
###xml 25 46 <span type="species:ncbi:11786">murine leukemia virus</span>
mink cell focus-inducing murine leukemia virus
###end p 106
###begin p 107
###xml 0 6 <span type="species:ncbi:10090">murine</span>
murine type C retrovirus
###end p 107
###begin p 108
###xml 0 21 <span type="species:ncbi:11786">murine leukemia virus</span>
murine leukemia virus
###end p 108
###begin p 109
nucleotide(s)
###end p 109
###begin p 110
New Zealand Black 9-1 xenotropic retrovirus
###end p 110
###begin p 111
open reading frame
###end p 111
###begin p 112
phosphate-buffered saline
###end p 112
###begin p 113
polymerase chain reaction
###end p 113
###begin p 114
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
RNASEL homozygous R462Q
###end p 114
###begin p 115
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
RNASEL heterozygous R462Q
###end p 115
###begin p 116
Ribonuclease L
###end p 116
###begin p 117
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
RNASEL homozygous wild-type
###end p 117
###begin p 118
###xml 0 26 <span type="species:ncbi:11819">spleen focus-forming virus</span>
spleen focus-forming virus
###end p 118
###begin p 119
variable region
###end p 119
###begin p 120
###xml 0 29 <span type="species:ncbi:438045">xenotropic MuLV-related virus</span>
xenotropic MuLV-related virus
###end p 120
###begin p 121
xenotropic and polytropic retrovirus receptor
###end p 121
###begin title 122
References
###end title 122
###begin article-title 123
pppA2'p5'A2'p5'A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells
###end article-title 123
###begin article-title 124
Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action
###end article-title 124
###begin article-title 125
2-5A-dependent RNase molecules dimerize during activation by 2-5A
###end article-title 125
###begin article-title 126
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L
###end article-title 126
###begin article-title 127
RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection
###end article-title 127
###begin article-title 128
A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system
###end article-title 128
###begin article-title 129
An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase
###end article-title 129
###begin article-title 130
HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand
###end article-title 130
###begin article-title 131
Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates
###end article-title 131
###begin article-title 132
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
###end article-title 132
###begin article-title 133
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
###end article-title 133
###begin article-title 134
A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews
###end article-title 134
###begin article-title 135
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer
###end article-title 135
###begin article-title 136
Prostate cancer
###end article-title 136
###begin article-title 137
Hereditary prostate cancer: Epidemiologic and clinical features
###end article-title 137
###begin article-title 138
Implications for RNase L in prostate cancer biology
###end article-title 138
###begin article-title 139
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 125 133 <span type="species:ncbi:9606">patients</span>
Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer
###end article-title 139
###begin article-title 140
Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer
###end article-title 140
###begin article-title 141
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
###end article-title 141
###begin article-title 142
Microarray-based detection and genotyping of viral pathogens
###end article-title 142
###begin article-title 143
Viral discovery and sequence recovery using DNA microarrays
###end article-title 143
###begin article-title 144
E-Predict: A computational strategy for species identification based on observed DNA microarray hybridization patterns
###end article-title 144
###begin article-title 145
Complete nucleotide sequence of an infectious clone of Friend spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein
###end article-title 145
###begin article-title 146
###xml 86 107 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75
###end article-title 146
###begin article-title 147
Database resources of the National Center for Biotechnology
###end article-title 147
###begin article-title 148
###xml 88 117 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Evidence that a downstream pseudoknot is required for translational read-through of the Moloney murine leukemia virus gag stop codon
###end article-title 148
###begin article-title 149
###xml 23 48 <span type="species:ncbi:11791">AKV murine leukemia virus</span>
Nucleotide sequence of AKV murine leukemia virus
###end article-title 149
###begin article-title 150
###xml 82 103 <span type="species:ncbi:11786">murine leukemia virus</span>
Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukemia virus
###end article-title 150
###begin article-title 151
###xml 32 60 <span type="species:ncbi:11795">Friend murine leukemia virus</span>
Complete nucleotide sequence of Friend murine leukemia virus, strain FB29
###end article-title 151
###begin article-title 152
###xml 31 37 <span type="species:ncbi:10090">murine</span>
Nucleotide sequence of Moloney murine leukaemia virus
###end article-title 152
###begin article-title 153
###xml 23 44 <span type="species:ncbi:11786">murine leukemia virus</span>
Cloning of the MCF1233 murine leukemia virus and identification of sequences involved in viral tropism, oncogenicity and T cell epitope formation
###end article-title 153
###begin article-title 154
###xml 61 82 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
Envelope and long terminal repeat sequences of an infectious murine leukemia virus from a human SCLC cell line: Implications for gene transfer
###end article-title 154
###begin article-title 155
###xml 102 125 <span type="species:ncbi:11786">murine leukemia viruses</span>
Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses
###end article-title 155
###begin article-title 156
###xml 15 36 <span type="species:ncbi:11786">murine leukemia virus</span>
Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution
###end article-title 156
###begin article-title 157
Cell surface receptors for gammaretroviruses
###end article-title 157
###begin article-title 158
###xml 11 17 <span type="species:ncbi:10090">murine</span>
Endogenous murine leukemia proviral long terminal repeats contain a unique 190-base-pair insert
###end article-title 158
###begin article-title 159
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 60 83 <span type="species:ncbi:11786">murine leukemia viruses</span>
A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: Possible role in G protein-coupled signal transduction
###end article-title 159
###begin article-title 160
###xml 86 109 <span type="species:ncbi:11786">murine leukemia viruses</span>
Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses
###end article-title 160
###begin article-title 161
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1
###end article-title 161
###begin article-title 162
Structure, variation and synthesis of retrovirus long terminal repeat
###end article-title 162
###begin article-title 163
###xml 31 52 <span type="species:ncbi:11786">murine leukemia virus</span>
Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness
###end article-title 163
###begin article-title 164
###xml 74 103 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer
###end article-title 164
###begin article-title 165
Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer
###end article-title 165
###begin article-title 166
###xml 65 93 <span type="species:ncbi:11809">Moloney murine sarcoma virus</span>
Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus
###end article-title 166
###begin article-title 167
###xml 65 71 <span type="species:ncbi:10090">murine</span>
A glucocorticoid response element in the LTR U3 region of Friend murine leukaemia virus variant FIS-2 enhances virus production in vitro and is a major determinant for sex differences in susceptibility to FIS-2 infection in vivo
###end article-title 167
###begin article-title 168
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 123 129 <span type="species:ncbi:10090">murine</span>
Gender-related differences in susceptibility, early virus dissemination and immunosuppression in mice infected with Friend murine leukaemia virus variant FIS-2
###end article-title 168
###begin article-title 169
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Oncogenicity and U3 region sequences of class II recombinant MuLVs of CWD mice
###end article-title 169
###begin article-title 170
###xml 38 59 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Structures of endogenous nonecotropic murine leukemia virus (MLV) long terminal repeats in wild mice: Implication for evolution of MLVs
###end article-title 170
###begin article-title 171
###xml 32 38 <span type="species:ncbi:10090">murine</span>
Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions
###end article-title 171
###begin article-title 172
###xml 69 98 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus
###end article-title 172
###begin article-title 173
###xml 62 83 <span type="species:ncbi:11786">murine leukemia virus</span>
An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors
###end article-title 173
###begin article-title 174
###xml 42 71 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor
###end article-title 174
###begin article-title 175
###xml 83 104 <span type="species:ncbi:11786">murine leukemia virus</span>
CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus
###end article-title 175
###begin article-title 176
###xml 37 66 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Construction and characterization of Moloney murine leukemia virus mutants unable to synthesize glycosylated gag polyprotein
###end article-title 176
###begin article-title 177
###xml 20 49 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent
###end article-title 177
###begin article-title 178
###xml 40 44 <span type="species:ncbi:10090">Mice</span>
###xml 105 111 <span type="species:ncbi:10090">Murine</span>
Recovery of Glycosylated gag Virus from Mice Infected with a Glycosylated gag-Negative Mutant of Moloney Murine Leukemia Virus
###end article-title 178
###begin article-title 179
###xml 108 131 <span type="species:ncbi:11786">murine leukemia viruses</span>
A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses
###end article-title 179
###begin article-title 180
###xml 66 87 <span type="species:ncbi:11786">murine leukemia virus</span>
Characterization of glycosylated Gag expressed by a neurovirulent murine leukemia virus: Identification of differences in processing in vitro and in vivo
###end article-title 180
###begin article-title 181
10A1-MuLV but not the related amphotropic 4070A MuLV is highly neurovirulent: Importance of sequences upstream of the structural Gag coding region
###end article-title 181
###begin article-title 182
The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: Analysis of second site revertants of a mutant MuLV lacking expression of this protein
###end article-title 182
###begin article-title 183
###xml 27 33 <span type="species:ncbi:10090">murine</span>
The neuroinvasiveness of a murine retrovirus is influenced by a dileucine-containing sequence in the cytoplasmic tail of glycosylated Gag
###end article-title 183
###begin article-title 184
Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity
###end article-title 184
###begin article-title 185
Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma
###end article-title 185
###begin article-title 186
###xml 56 79 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 143 164 <span type="species:ncbi:11786">murine leukemia virus</span>
Characterization of monoclonal antibodies reactive with murine leukemia viruses: Use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus
###end article-title 186
###begin article-title 187
###xml 54 77 <span type="species:ncbi:11786">murine leukemia viruses</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Structure and distribution of endogenous nonecotropic murine leukemia viruses in wild mice
###end article-title 187
###begin article-title 188
###xml 11 17 <span type="species:ncbi:10090">murine</span>
A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection
###end article-title 188
###begin article-title 189
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Transport of cationic amino acids by the mouse ecotropic retrovirus receptor
###end article-title 189
###begin article-title 190
###xml 36 42 <span type="species:ncbi:10090">murine</span>
Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter
###end article-title 190
###begin article-title 191
The evolution, distribution and diversity of endogenous retroviruses
###end article-title 191
###begin article-title 192
Know thy neighbor: Stromal cells can contribute oncogenic signals
###end article-title 192
###begin article-title 193
Stromal fibroblasts in cancer initiation and progression
###end article-title 193
###begin article-title 194
###xml 71 76 <span type="species:ncbi:9606">human</span>
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
###end article-title 194
###begin article-title 195
Cluster analysis and display of genome-wide expression patterns
###end article-title 195
###begin article-title 196
Java Treeview-Extensible visualization of microarray data
###end article-title 196
###begin article-title 197
Consed: A graphical tool for sequence finishing
###end article-title 197
###begin article-title 198
###xml 31 52 <span type="species:ncbi:11786">murine leukemia virus</span>
The four classes of endogenous murine leukemia virus: Structural relationships and potential for recombination
###end article-title 198
###begin article-title 199
The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools
###end article-title 199
###begin article-title 200
Multiple sequence alignment with Clustal X
###end article-title 200
###begin article-title 201
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences
###end article-title 201
###begin article-title 202
AVID: A global alignment program
###end article-title 202
###begin article-title 203
VISTA: Computational tools for comparative genomics
###end article-title 203
###begin title 204
Figures and Tables
###end title 204
###begin title 205
###xml 0 4 <span type="species:ncbi:438045">XMRV</span>
XMRV Detection by DNA Microarrays and RT-PCR
###end title 205
###begin p 206
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x-</italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y-</italic>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
(A) Virochip hybridization patterns obtained for tumor samples from 19 patients. The samples (x-axis) and the 502 retroviral oligonucleotides present on the microarray (y-axis) were clustered using hierarchical clustering. The red color saturation indicates the magnitude of hybridization intensity.
###end p 206
###begin p 207
###xml 135 141 135 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNASEL</italic>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
(B) Magnified view of a selected cluster containing oligonucleotides with the strongest positive signal. Samples from patients with QQ RNASEL genotype are shown in red, and those from RQ and RR individuals as well as controls are in black.
###end p 207
###begin p 208
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 42 46 <span type="species:ncbi:438045">XMRV</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
(C) Results of nested RT-PCR specific for XMRV gag gene. Amplified gag PCR fragments along with the corresponding human GAPDH amplification controls were separated by gel electrophoresis using the same lane order as in the microarray cluster.
###end p 208
###begin title 209
###xml 19 23 <span type="species:ncbi:438045">XMRV</span>
Complete Genome of XMRV
###end title 209
###begin p 210
###xml 33 37 <span type="species:ncbi:438045">XMRV</span>
###xml 135 138 <span type="species:ncbi:103820">Gag</span>
###xml 140 143 <span type="species:ncbi:103820">Gag</span>
(A) Schematic map of the 8185 nt XMRV genome. LTR regions (R, U5, U3) are indicated with boxes. Predicted open reading frames encoding Gag, Gag-Pro-Pol, and Env polyproteins are labeled in green. The corresponding start and stop codons (AUG, UAG, UGA, UAA) as well as the alternative Gag start codon (CUG) are shown with their nt positions. Similarly, splice donor (SD) and acceptor (SA) sites are shown and correspond to the spliced 3.2-Kb Env subgenomic RNA (wiggled line).
###end p 210
###begin p 211
###xml 246 254 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0020025-st002">Table S2</xref>
###xml 30 34 <span type="species:ncbi:438045">XMRV</span>
(B) Cloning and sequencing of XMRV VP35 and VP62 genomes. Clones obtained by probe recovery from hybridizing microarray oligonucleotides (blue bar) or by PCR from tumor cDNA (black bars) were sequenced. Primers used to amplify individual clones (Table S2) were derived either from the genome of MTCR (black arrows) or from overlapping VP35 clones (blue arrows).
###end p 211
###begin p 212
###xml 168 189 168 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b081">81</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b082">82</xref>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</italic>
###xml 47 51 <span type="species:ncbi:438045">XMRV</span>
###xml 62 66 <span type="species:ncbi:438045">XMRV</span>
###xml 73 77 <span type="species:ncbi:438045">XMRV</span>
(C) Genome sequence similarity plots comparing XMRV VP35 with XMRV VP42, XMRV VP62, MuLV DG-75, MTCR, and a set of representative non-ecotropic proviruses (mERVs) (see Materials and Methods). The alignments were made using AVID [81], and plots were generated using mVISTA [82] with the default window size of 100 nt. Y-axis scale for each plot represents percent nt identities from 50% to 100%. Sequences are labeled as xenotropic (X), polytropic (P), or modified polytropic (Pm).
###end p 212
###begin title 213
###xml 25 29 <span type="species:ncbi:438045">XMRV</span>
Phylogenetic Analysis of XMRV Based on Complete Genome Sequences
###end title 213
###begin p 214
###xml 290 311 290 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 20 24 <span type="species:ncbi:438045">XMRV</span>
###xml 108 129 <span type="species:ncbi:11768">feline leukemia virus</span>
###xml 131 134 <span type="species:ncbi:11768">FLV</span>
###xml 137 153 <span type="species:ncbi:394239">koala retrovirus</span>
###xml 155 159 <span type="species:ncbi:394239">KoRV</span>
###xml 162 187 <span type="species:ncbi:11840">gibbon ape leukemia virus</span>
###xml 189 193 <span type="species:ncbi:11840">GALV</span>
Complete genomes of XMRV VP35, VP42, and VP62 (red); MTCR; MuLVs DG-75, AKV, Moloney, Friend, and Rauscher; feline leukemia virus (FLV); koala retrovirus (KoRV); gibbon ape leukemia virus (GALV); and a set of representative non-ecotropic proviruses (mERVs) were aligned using ClustalX (see Materials and Methods). An unrooted neighbor-joining tree was generated based on this alignment, excluding gaps and using Kimura's correction for multiple base substitutions. Bootstrap values (n = 1000 trials) are indicated as percentages. Sequences are labeled as xenotropic (X), polytropic (P), modified polytropic (Pm), or ecotropic (E).
###end p 214
###begin title 215
###xml 54 58 <span type="species:ncbi:438045">XMRV</span>
Multiple-Sequence Alignment of Protein Sequences from XMRV and Related MuLVs Spanning SU Glycoprotein VRA, VRB, and VRC, Known to Determine Receptor Specificity
###end title 215
###begin p 216
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0020025-b077">77</xref>
###xml 26 30 <span type="species:ncbi:438045">XMRV</span>
###xml 390 394 <span type="species:ncbi:438045">XMRV</span>
Env protein sequence from XMRV (identical in VP35, VP42, and VP62; red); MTCR; MuLVs DG-75, NZB-9-1, NFS-Th-1, MCF247, AKV, Moloney, Friend, and Rauscher; and polytropic proviruses MX27 and MX33 [77] were aligned using ClustalX. Sequences are labeled as xenotropic (X), polytropic (P), modified polytropic (Pm), or ecotropic (E). VRs are boxed. Dots denote residues identical to those from XMRV, and deleted residues appear as spaces.
###end p 216
###begin title 217
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 71 75 <span type="species:ncbi:438045">XMRV</span>
Multiple-Sequence Alignment of 5' gag Leader Nucleotide Sequences from XMRV and Related MuLVs
###end title 217
###begin p 218
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 271 292 271 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 113 117 <span type="species:ncbi:438045">XMRV</span>
###xml 566 570 <span type="species:ncbi:438045">XMRV</span>
Sequences extending from the alternative CUG start codon to the AUG start codon (underlined) of gag derived from XMRV VP35, VP42, and VP62 (blue); MTCR, MuLVs DG-75, and Friend; and a set of representative non-ecotropic proviruses (mERVs) were aligned with ClustalX (see Materials and Methods). Predicted amino acid translation corresponding to the VP35 sequence is shown above the alignment (red); asterisk indicates a stop. Sequences are labeled as xenotropic (X), polytropic (P), modified polytropic (Pm), or ecotropic (E). Dots denote nt identical to those from XMRV, and deleted nt appear as spaces.
###end p 218
###begin title 219
###xml 14 18 <span type="species:ncbi:438045">XMRV</span>
###xml 69 77 <span type="species:ncbi:9606">Patients</span>
Comparison of XMRV Sequences Derived from Tumor Samples of Different Patients
###end title 219
###begin p 220
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 395 416 395 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 42 46 <span type="species:ncbi:438045">XMRV</span>
(A) Phylogenetic tree based on the 380 nt XMRV gag RT-PCR fragment from the nine positive tumor samples (red) and the corresponding sequences from MTCR; MuLVs DG-75, MCF1233, Akv, Moloney, Rauscher and Friend; and a set of representative non-ecotropic proviruses (mERVs). The sequences were aligned using ClustalX, and the corresponding tree was generated using the neighbor-joining method (see Materials and Methods). Bootstrap values (n = 1000 trials) are indicated as percentages. Sequences are labeled as xenotropic (X), polytropic (P), modified polytropic (Pm), or ecotropic (E).
###end p 220
###begin p 221
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 69 73 <span type="species:ncbi:438045">XMRV</span>
(B) Phylogenetic tree based on a 2500-nt pol PCR fragment from the 9 XMRV-positive tumor samples. The tree was constructed as described in (A).
###end p 221
###begin title 222
###xml 13 17 <span type="species:ncbi:438045">XMRV</span>
Detection of XMRV Nucleic Acid in Prostatic Tissues Using FISH
###end title 222
###begin p 223
###xml 132 136 <span type="species:ncbi:438045">XMRV</span>
Prostatic tumor tissue sections from QQ cases VP62 (A-C) and VP88 (D-F) were analyzed by FISH using DNA probes (green) derived from XMRV VP35 (top right enlargements). Nuclei were counterstained with DAPI. The same sections were then visualized by H&E staining (left panels). Scale bars are 10 mum. Arrows indicate FISH positive cells, and their enlarged images are shown in the bottom right panels.
###end p 223
###begin title 224
###xml 20 24 <span type="species:ncbi:438045">XMRV</span>
Characterization of XMRV-Infected Prostatic Cells by FISH and FISH/Immunofluorescence
###end title 224
###begin p 225
###xml 137 141 <span type="species:ncbi:438045">XMRV</span>
Using a tissue microarray, prostatic tumor tissue sections from QQ case VP62 were analyzed by FISH (green) using DNA probes derived from XMRV VP35 (left panels). Nuclei were counterstained with DAPI. The same sections were then visualized by H&E staining (middle panels). Arrows indicate FISH-positive cells, and their enlarged FISH and H&E images are shown in the top right and bottom right panels, respectively. Scale bars are 10 mum.
###end p 225
###begin p 226
(A) A stromal fibroblast.
###end p 226
###begin p 227
(B) A dividing stromal cell.
###end p 227
###begin p 228
###xml 76 80 <span type="species:ncbi:438045">XMRV</span>
(C) A stromal hematopoietic cell. The section was concomitantly stained for XMRV by FISH (green) and cytokeratin AE1/AE3 by immunofluorescence (red).
###end p 228
###begin title 229
###xml 13 17 <span type="species:ncbi:438045">XMRV</span>
Detection of XMRV Protein in Prostatic Tissues Using Immunostaining
###end title 229
###begin p 230
###xml 227 231 <span type="species:ncbi:11819?1.0">SFFV</span>
Prostatic tumor tissue sections from QQ cases VP62 (A and B) and VP88 (C and D), as well as an RR case VP51 (E) were stained, then visualized by immunofluorescence (left) or bright field (middle) using a monoclonal antibody to SFFV Gag protein. Nuclei are counterstained with hematoxylin. Enlarged images corresponding to the positive cells are shown on the right. Scale bars are 5 mum in (A), (B), and (E) and 10 mum in (C) and (D).
###end p 230
###begin p 231
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 0 4 <span type="species:ncbi:438045">XMRV</span>
XMRV Screening by gag Nested RT-PCR
###end p 231
###begin p 232
###xml 13 17 <span type="species:ncbi:438045">XMRV</span>
Frequency of XMRV-Infected Prostatic Cells Determined by FISH
###end p 232
###begin p 233
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. AU, RJM, NF, DG, RHS, and JLD conceived and designed the experiments. AU, RJM, NF, SJP, KM, CMG, and RRT performed the experiments. AU, RJM, NF, SJP, GC, EAK, KM, CMG, RRT, DG, RHS, and JLD analyzed the data. AU, RJM, NF, SJP, GC, EAK, DG, RHS, and JLD contributed reagents/materials/analysis tools. AU, RJM, NF, DG, RHS, and JLD wrote the paper.
###end p 233
###begin p 234
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 234
###begin p 235
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This investigation was supported by Genentech Graduate Fellowship and a grant from the Sandler Family Supporting Foundation (AU), grants from Doris Duke Charitable Foundation (JLD and DG) and the David and Lucille Packard Foundation (JLD), Howard Hughes Medical Institute (JLD and DG), by NIH/NCI grants (to RHS and GC), and a Molecular Medicine Fellowship from Cleveland State University and the Cleveland Clinic Foundation (RJM).
###end p 235
###begin p 236
###xml 144 152 <span type="species:ncbi:9606">patients</span>
Citation: Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2(3): e25.
###end p 236

